
Quidel Corporation QDEL
$ 14.23
2.74%
Quidel Corporation EV - Enterprise Value 2011-2026 | QDEL
Annual EV - Enterprise Value Quidel Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 460 M | 4.4 B | 4.62 B | 4.77 B | 9.76 B | 9.25 B | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.76 B | 460 M | 5.54 B |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioNano Genomics
BNGO
|
34.1 M | $ 1.14 | 0.44 % | $ 6.21 M | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 16.07 | 1.39 % | $ 173 M | ||
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
45.8 B | $ 115.09 | 0.03 % | $ 35 B | ||
|
Interpace Biosciences
IDXG
|
16.3 M | $ 2.25 | -2.17 % | $ 9.95 M | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 16.32 | 1.65 % | $ 870 M | ||
|
Medpace Holdings
MEDP
|
14 B | $ 498.22 | 0.95 % | $ 14.4 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Myriad Genetics
MYGN
|
598 M | $ 4.45 | 2.3 % | $ 412 M | ||
|
NeoGenomics
NEO
|
1.85 B | $ 7.87 | 2.34 % | $ 1.01 B | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-1.92 M | $ 1.4 | 2.19 % | $ 1.86 M | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 23.05 | -0.35 % | $ 640 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
Senseonics Holdings
SENS
|
376 M | $ 6.62 | -0.9 % | $ 276 M | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 176.51 | 0.49 % | $ 8.75 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Soleno Therapeutics
SLNO
|
2.13 B | $ 52.58 | -0.1 % | $ 2.67 B | ||
|
Danaher Corporation
DHR
|
145 B | $ 190.99 | 0.73 % | $ 136 B | ||
|
Neuronetics
STIM
|
168 M | $ 1.37 | 1.11 % | $ 90.4 M | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
15.3 B | $ 122.69 | 1.46 % | $ 19.5 B | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 14.96 | 3.67 % | $ 452 M | ||
|
Thermo Fisher Scientific
TMO
|
186 B | $ 500.25 | 0.83 % | $ 189 B | ||
|
Trinity Biotech plc
TRIB
|
133 M | $ 0.69 | -3.28 % | $ 61.9 M | ||
|
Guardant Health
GH
|
15.2 B | $ 79.27 | 0.85 % | $ 9.94 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
1.55 B | $ 48.44 | 1.11 % | $ 2.9 B | ||
|
Anixa Biosciences
ANIX
|
990 K | $ 2.73 | 1.49 % | $ 88.6 K | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.1 | -2.1 % | $ 4.82 M | ||
|
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | ||
|
Koninklijke Philips N.V.
PHG
|
13.2 B | $ 28.26 | -0.18 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 107.45 | 0.59 % | $ 8.86 B | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 261.12 | 0.07 % | $ 21.7 B | ||
|
Natera
NTRA
|
5.53 B | $ 197.55 | 2.34 % | $ 19.4 B | ||
|
Celcuity
CELC
|
5.57 B | $ 118.08 | 0.8 % | $ 5.52 B | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 80.41 | -0.23 % | $ 5.43 B | ||
|
Waters Corporation
WAT
|
21.6 B | $ 318.26 | -0.54 % | $ 19 B |